Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and β-catenin pathways

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7318-7324

  Satyamoorthy, Kapaettu ^a   Li, Gang ^a,b   Vaidya, Bhavesh ^a   Patel, Dipa ^a   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C;

ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GROWTH REGULATION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BETA CATENIN; CELL DIVISION; CELL SURVIVAL; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; ENZYME ACTIVATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MELANOMA; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0035477424     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Dynamics of intercellular communication during melanoma development
2. Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes
3. Growth factors and melanomas
4. Development of invasive and growth factor-independent cell variants from primary human melanomas
5. Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro
6. Biology of tumor progression in human melanocytes
7. Interactions of melanocytes and melanoma cells with the microenvironment
8. Role of growth factors and their receptors in the development and progression of melanoma
9. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice
10. Characteristics of cultured human melanocytes isolated from different stages of tumor progression
11. Primary melanoma cells of the vertical growth phase: Similarities to metastatic cells
12. Heterogeneity of the motility responses in malignant tumor cells: A biological basis for the diversity and homing of metastatic cells
13. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells
14. Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: A potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins
15. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: A potential therapeutic target
16. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor
17. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion
18. The IGF-I receptor and cancer
19. The IGF-I receptor in cancer research
20. The role of the insulin-like growth factor I receptor in transformation and apoptosis
21. Antiapoptotic signalling by the insulin-like growth factor I receptor phosphatidylinositol 3-kinase and Akt
22. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I
23. AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells
24. Mechanism of activation of protein kinase B by insulin and IGF-1
25. Signal transduction by β1 integrin receptors in human chondrocytes in vitro: Collaboration with the insulin-like growth factor-I receptor
26. Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells
27. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways
28. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9
29. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I
30. In vitro properties of human melanoma cells metastatic in nude mice
31. Isolation of the human insulin-like growth factor 1 gene using a single synthetic DNA probe
32. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
33. Insulin-like growth factor-1-mediated survival from anoikis: Role of cell aggregation and focal adhesion kinase
34. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons
35. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action
36. Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion
37. Melanoma cell lines from different stages of progression and their biological and molecular analyses
38. Methods for construction of adenovirus vectors
39. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
40. Insulin-like growth factor-1 receptor. Its role in cell proliferation, apoptosis, and tumorigenicity
41. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors
42. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation
43. Human melanoma progression in skin reconstructs: Biological significance of bFGF
44. Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes
45. Cellular survival: A play in three Akts
46. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway
47. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
48. N-Cadherin-mediated intercellular interactions promote survival and migration of melanoma cells